Health ❯Vaccines

RSV Vaccines

FDA Approval Pfizer GSK Vaccine Effectiveness Vaccine Safety Vaccine Pricing Arexvy Alternate Strategies

FDA Expands Approval of GSK's RSV Vaccine to Adults Aged 50-59

First RSV Vaccine Approved for Older Adults Amid Rising Infections

Updated COVID boosters with omicron targeting expected mid-September pending FDA and CDC approval

Health Officials Brace for Flu, Covid and R.S.V. 'Tripledemic'

CDC Panel Unanimously Recommends RSV Vaccines for Seniors